Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Prediction and management of small-for-size syndrome in living donor liver transplantation

Jia-hao Law, Alfred Wei-Chieh Kow

Clin Mol Hepatol. 2025;31(Suppl):S301-S326. Published online December 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0870

View: 838 Download: 86

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation

Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia

Clin Mol Hepatol. 2025;31(Suppl):S285-S300. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0323

View: 1714 Download: 171 Crossref: 1

Correspondence

Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Soon Kyu Lee, Jong Young Choi

Clin Mol Hepatol. 2025;31(2):e212-e214. Published online February 10, 2025

DOI: https://doi.org/10.3350/cmh.2025.0100

View: 321 Download: 17

Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Soon Kyu Lee, Jong Young Choi

Clin Mol Hepatol. 2025;31(2):e161-e162. Published online February 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0121

View: 319 Download: 20

Letter to the Editor

Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Rui Shi, Minghua Wang

Clin Mol Hepatol. 2025;31(2):e137-e139. Published online January 9, 2025

DOI: https://doi.org/10.3350/cmh.2024.1159

View: 473 Download: 31

Editorial

Intrapatient variability of tacrolimus trough level may be not the cause, but an indirect parameter of comorbidities: Editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Jongman Kim

Clin Mol Hepatol. 2025;31(2):589-591. Published online January 24, 2025

DOI: https://doi.org/10.3350/cmh.2025.0076

View: 409 Download: 32 Crossref: 1

Original Article

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation

Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi

Clin Mol Hepatol. 2025;31(1):131-146. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0451

View: 1585 Download: 181 Crossref: 2

Snapshot

Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations

Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen

Clin Mol Hepatol. 2024;30(3):582-584. Published online December 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0555

View: 9581 Download: 105

Original Article

Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts

Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He, Weiqiang Ju, Maogen Chen

Clin Mol Hepatol. 2024;30(3):421-435. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0139

View: 3266 Download: 158 Web of Science: 2 Crossref: 3

Review

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management

Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra

Clin Mol Hepatol. 2023;29(Suppl):S286-S301. Published online December 28, 2022

DOI: https://doi.org/10.3350/cmh.2022.0392

View: 8045 Download: 283 Web of Science: 22 Crossref: 30

Editorial

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

Byeong Geun Song, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(2):411-413. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0058

View: 3267 Download: 54 Web of Science: 1 Crossref: 2

Review

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective

Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2023;29(2):217-229. Published online December 28, 2022

DOI: https://doi.org/10.3350/cmh.2022.0399

View: 7437 Download: 262 Web of Science: 14 Crossref: 16

Management of refractory ascites

Florence Wong

Clin Mol Hepatol. 2023;29(1):16-32. Published online June 9, 2022

DOI: https://doi.org/10.3350/cmh.2022.0104

View: 13320 Download: 1,038 Web of Science: 26 Crossref: 28

Original Article

COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis

Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen

Clin Mol Hepatol. 2022;28(4):890-911. Published online June 3, 2022

DOI: https://doi.org/10.3350/cmh.2022.0087

View: 6527 Download: 191 Web of Science: 33 Crossref: 34

Review

Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review

Sang Jin Kim, Jong Man Kim

Clin Mol Hepatol. 2022;28(4):739-753. Published online April 26, 2022

DOI: https://doi.org/10.3350/cmh.2022.0060

View: 6137 Download: 189 Web of Science: 20 Crossref: 21

Snapshot

Microbiome and metabolomics in alcoholic liver disease

Raja Ganesan, Ki Tae Suk

Clin Mol Hepatol. 2022;28(3):580-582. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0171

View: 6497 Download: 176 Web of Science: 14 Crossref: 13

Current status and outcome of liver transplantation in South Korea

Ho Joong Choi

Clin Mol Hepatol. 2022;28(1):117-119. Published online December 7, 2021

DOI: https://doi.org/10.3350/cmh.2021.0381

View: 7438 Download: 101 Web of Science: 14 Crossref: 17

Original Article

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

DOI: https://doi.org/10.3350/cmh.2021.0202

View: 5911 Download: 185 Web of Science: 2 Crossref: 2

Review

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0217

View: 10890 Download: 364 Web of Science: 44 Crossref: 48

Original Article

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea

Kyeong Deok Kim, Ji Eun Lee, Jong Man Kim, Okjoo Lee, Na Young Hwang, Jinsoo Rhu, Gyu-Seong Choi, Kyunga Kim, Jae-Won Joh

Clin Mol Hepatol. 2021;27(4):603-615. Published online September 8, 2021

DOI: https://doi.org/10.3350/cmh.2021.0137

View: 6253 Download: 149 Web of Science: 5 Crossref: 4

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma

Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo

Clin Mol Hepatol. 2021;27(4):589-602. Published online July 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0038

View: 7235 Download: 261 Web of Science: 23 Crossref: 24

Editorial

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?

Jong Man Kim

Clin Mol Hepatol. 2021;27(4):562-563. Published online September 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0276

View: 4838 Download: 139 Web of Science: 4 Crossref: 3

Original Article

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry

Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim

Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021

DOI: https://doi.org/10.3350/cmh.2020.0292

View: 8748 Download: 328 Web of Science: 40 Crossref: 43

Review

Changes in the epidemiology and management of bacterial infections in cirrhosis

Salvatore Piano, Marta Tonon, Paolo Angeli

Clin Mol Hepatol. 2021;27(3):437-445. Published online January 28, 2021

DOI: https://doi.org/10.3350/cmh.2020.0329

View: 9419 Download: 435 Web of Science: 40 Crossref: 45

Editorial

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0305

View: 5561 Download: 149 Web of Science: 8 Crossref: 8

Review

Liver graft from donation after circulatory death donor: Real practice to improve graft viability

Koji Hashimoto

Clin Mol Hepatol. 2020;26(4):401-410. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0072

View: 7786 Download: 178 Web of Science: 11 Crossref: 14

Fecal microbiota transplantation in alcohol related liver diseases

Saggere Muralikrishna Shasthry

Clin Mol Hepatol. 2020;26(3):294-301. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0057

View: 8545 Download: 241 Web of Science: 29 Crossref: 32

Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?

Keun Soo Ahn, Koo Jeong Kang

Clin Mol Hepatol. 2019;25(4):354-359. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0096

View: 8907 Download: 372 Web of Science: 48 Crossref: 46

Original Article

Evaluation of bioenergetic and mitochondrial function in liver transplantation

Rui Miguel Martins, João Soeiro Teodoro, Emanuel Furtado, Anabela Pinto Rolo, Carlos Marques Palmeira, José Guilherme Tralhão

Clin Mol Hepatol. 2019;25(2):190-198. Published online March 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0087

View: 8075 Download: 175 Web of Science: 9 Crossref: 7

Fatigue and weakness hinder patient social reintegration after liver transplantation

So Hyun Kang, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Sungho Kim, Kil Hwan Kim, In Gun Hyun, Ahmed Shehta

Clin Mol Hepatol. 2018;24(4):402-408. Published online October 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0028

View: 11096 Download: 121 Web of Science: 12 Crossref: 13

1 | 2 | 3 |

Viewed By 8477	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7416	MAFLD: How is it different from NAFLD?
Viewed By 5377	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5007	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4548	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 291	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search